Health Sciences Centre, Winnipeg, Manitoba
19
5
5
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
10.5%
2 terminated/withdrawn out of 19 trials
77.8%
-8.7% vs industry average
16%
3 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Statins In Intracerbral Hemorrhage
Role: collaborator
Assessing the Feasibility of a Virtual Reality Intervention for Phantom Pain Immediately Following Lower Limb Amputation
Role: collaborator
Non-Invasive Mapping of Cerebral Autoregulation Using Near Infrared Spectroscopy
Role: collaborator
Pharmacogenomics-Supported Psychotropic Prescribing Trial
Role: collaborator
Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis
Role: collaborator
Best Practices Fo Early Diagnosis of Cerebral Palsy
Role: collaborator
Powdered Intrawound Vancomycin in Open Fractures Trial
Role: collaborator
Canadian National PDA Treatment Study
Role: collaborator
The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN)
Role: collaborator
Pulmonary Rehabilitation Post-COVID-19
Role: collaborator
IBD Neoplasia Surveillance Pilot RCT
Role: collaborator
The Canada Lymph Node Score Project: A Crossover Trial
Role: collaborator
Indomethacin PK-PD in Extremely Preterm Neonates
Role: collaborator
Lung Ultrasound for Prediction of Bronchopulmonary Dysplasia
Role: collaborator
Budesonide With Intratracheal Surfactants in Extremely Preterm Infants
Role: collaborator
MDS-CAN: A Prospective National MDS Clinical Database and Local Tissue Bank
Role: collaborator
Family Integrated Care in the NICU
Role: collaborator
Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.
Role: collaborator
Oral Testosterone for Fatigue in Male Multiple Sclerosis Patients
Role: lead
All 19 trials loaded